Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization
Micah Belzberg, Martin P. Alphonse, Isabelle Brown, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 9, pp. 2208-2218.e14
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
Gil Yosipovitch, Nicholas Mollanazar, Sonja Ständer, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1180-1190
Open Access | Times Cited: 116
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring
Christeen Samuel, Hannah Cornman, Anusha Kambala, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 3, pp. 729-749
Open Access | Times Cited: 113
Neuroimmune communication regulating pruritus in atopic dermatitis
Martin Steinhoff, Fareed Ahmad, Atul Kumar Pandey, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1875-1898
Open Access | Times Cited: 86
Itch: Pathogenesis and treatment
Nishadh Sutaria, Waleed Adawi, Rebecca Goldberg, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 1, pp. 17-34
Closed Access | Times Cited: 75
Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab
Lam C. Tsoi, Fériel Hacini‐Rachinel, Paul Fogel, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 4, pp. 1329-1339
Open Access | Times Cited: 61
Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics
Shawn G. Kwatra, L. Misery, Claire Clibborn, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 5
Open Access | Times Cited: 39
Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis
Natalia Alkon, Frank P. Assen, T. Arnoldner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 2, pp. 420-435
Closed Access | Times Cited: 35
Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis
Jay Patel, Marina Z. Joel, Kevin K. Lee, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 7, pp. 1568-1578.e5
Closed Access | Times Cited: 15
Efficacy and Safety of Abrocitinib in Prurigo Nodularis and Chronic Pruritus of Unknown Origin
Shawn G. Kwatra, Zachary A. Bordeaux, Varsha Parthasarathy, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 7, pp. 717-717
Open Access | Times Cited: 10
Prurigo nodularis: new insights into pathogenesis and novel therapeutics
Viviane Liao, Hannah Cornman, Emily Ma, et al.
British Journal of Dermatology (2024) Vol. 190, Iss. 6, pp. 798-810
Closed Access | Times Cited: 8
Cutaneous Transcriptomics Identifies Fibroproliferative and Neurovascular Gene Dysregulation in Prurigo Nodularis Compared with Psoriasis and Atopic Dermatitis
Nishadh Sutaria, Martin P. Alphonse, Youkyung S. Roh, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 9, pp. 2537-2540
Open Access | Times Cited: 33
A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo Nodularis
Chirag Vasavda, Guihong Wan, Mindy D Szeto, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 12, pp. 2416-2426.e1
Closed Access | Times Cited: 18
Molecular mechanisms of pruritus in prurigo nodularis
Yixin Shao, Duoqin Wang, Yiqi Zhu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Clinical characteristics and disease burden in prurigo nodularis
Prachi Aggarwal, Justin Choi, Nishadh Sutaria, et al.
Clinical and Experimental Dermatology (2021) Vol. 46, Iss. 7, pp. 1277-1284
Closed Access | Times Cited: 40
Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans
Nishadh Sutaria, Martin P. Alphonse, Melika Marani, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 5, pp. 1300-1308.e3
Open Access | Times Cited: 34
Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
Shannon Wongvibulsin, Nishadh Sutaria, Suraj Kannan, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Chronic prurigo
L. Misery
British Journal of Dermatology (2022) Vol. 187, Iss. 4, pp. 464-471
Closed Access | Times Cited: 27
Transcriptomic, Epigenomic, and Neuroanatomic Signatures Differ in Chronic Prurigo, Atopic Dermatitis, and Brachioradial Pruritus
Konstantin Agelopoulos, Lina Renkhold, Henning Wiegmann, et al.
Journal of Investigative Dermatology (2022) Vol. 143, Iss. 2, pp. 264-272.e3
Open Access | Times Cited: 27
Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis
Junwen Deng, Varsha Parthasarathy, Melika Marani, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 27
Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment
Lai‐San Wong, Yu-Ta Yen
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12390-12390
Open Access | Times Cited: 24
The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis
Varsha Parthasarathy, Karen Cravero, Lillian Xu, et al.
Journal of the American Academy of Dermatology (2023) Vol. 88, Iss. 5, pp. 1101-1109
Open Access | Times Cited: 13
Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab
Junwen Deng, Viviane Liao, Varsha Parthasarathy, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 9, pp. 977-977
Open Access | Times Cited: 11
Spatial Mass Cytometry–Based Single-Cell Imaging Reveals a Disrupted Epithelial–Immune Axis in Prurigo Nodularis
Jay Patel, Junwen Deng, Anusha Kambala, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 11, pp. 2501-2512.e4
Closed Access | Times Cited: 4
Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping
Hannah Cornman, Martin P. Alphonse, Arbor G. Dykema, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Translating tissue expression of STAT 1, 3 and 6 in prurigo nodularis to clinical efficacy of oral tofacitinib – A prospective single-arm investigational study
Kabir Sardana, Sinu Rose Mathachan, Aishwarya Muddebihal, et al.
Indian Journal of Dermatology Venereology and Leprology (2025), pp. 1-6
Open Access
Page 1 - Next Page

Scroll to top